{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:50:23Z","timestamp":1771509023952,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Im Januar 2022 wird die 11.\u00a0Revision der International Classification of Diseases (ICD-11) in Kraft treten. Unter anderem wird darin die SEPSIS-3-Definition implementiert sein, in der Sepsis als \u201elebensbedrohliche Organdysfunktion, hervorgerufen durch eine fehlregulierte Wirtsantwort auf eine Infektion\u201c definiert wird. Ziel der vorliegenden Sekund\u00e4rauswertung einer Umfrage zum Thema \u201eSepsis-induzierte Koagulopathie\u201c war es zu evaluieren, ob die SEPSIS-3-Definition (engl. The Third International Consensus Definitions for Sepsis and Septic Shock) 4\u00a0Jahre nach ihrer internationalen Einf\u00fchrung im klinischen Alltag an\u00e4sthesiologisch gef\u00fchrter Intensivstationen in Deutschland angekommen ist und so die Voraussetzungen f\u00fcr die Verwendung des ICD-11 gegeben sind.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methoden<\/jats:title>\n                <jats:p>Im Rahmen einer deutschlandweiten Umfrage unter \u00e4rztlichen Leitern von Intensivstationen, die zwischen Oktober 2019 und Mai 2020 durchgef\u00fchrt wurde, wurde in einem gesonderten Fragenblock nach der verwendeten Sepsisdefinition gefragt. Zus\u00e4tzlich wurde gefragt, ob der quick-Sequential (Sepsis-related) Organ Failure Assessment (qSOFA) Score zum Screening auf Sepsis in dem Krankenhaus, zu dem die teilnehmende Intensivstation geh\u00f6rt, verwendet wird.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>Insgesamt nahmen 50\u00a0\u00e4rztliche Leiter von an\u00e4sthesiologisch gef\u00fchrten Intensivbereichen an der Umfrage teil. In Summe gaben die ausgewerteten Intensivstationen an, etwa 14,0\u202f% der in Deutschland registrierten High-Care-Betten zu f\u00fchren. An 78,9\u202f% der Universit\u00e4tsklinika und 84,0\u202f% der teilnehmenden Lehrkrankenh\u00e4user ist die SEPSIS-3-Definition im klinischen Alltag integriert. Im Gegensatz dazu wird der Screening-Test \u201eqSOFA\u201c nur von 26,3\u202f% der teilnehmenden Universit\u00e4tsklinika, aber immerhin von 52,0\u202f% der Lehrkrankenh\u00e4user und 80,0\u202f% der \u201esonstigen\u201c Krankenh\u00e4user verwendet.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Schlussfolgerung<\/jats:title>\n                <jats:p>Unsere Daten zeigen, dass sowohl SEPSIS\u20113 als auch qSOFA im klinischen Alltag deutscher Krankenh\u00e4user angekommen sind. Die zur\u00fcckhaltende Verwendung des qSOFA an Universit\u00e4tsklinika bei gleichzeitiger breiter Akzeptanz der SEPSIS-3-Definition kann als Indiz interpretiert werden, dass die Suche nach einem geeigneten Screeningtest f\u00fcr Sepsis noch nicht abgeschlossen ist.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00101-021-01012-8","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T13:03:14Z","timestamp":1628168594000},"page":"104-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["SEPSIS-3.0\u00a0\u2013 Ist die Intensivmedizin bereit f\u00fcr die ICD-11?","SEPSIS-3.0\u2014Is intensive care medicine ready for ICD-11?"],"prefix":"10.1007","volume":"71","author":[{"given":"Thomas","family":"Schmoch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bernhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Becker-Pennrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig Christian","family":"Hinske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Briegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"M\u00f6hnle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus A.","family":"Weigand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"SepNet Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"key":"1012_CR1","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1378\/chest.101.3.594","volume":"101","author":"RC Bone","year":"1992","unstructured":"Bone\u00a0RC (1992) Sepsis and coagulation. An important link. Chest 101:594\u2013596. https:\/\/doi.org\/10.1378\/chest.101.3.594","journal-title":"Chest"},{"key":"1012_CR2","unstructured":"Bundesinstitut f\u00fcr Arzeneimittel und Medizinprodukte (2019) Was versteht man unter SIRS \u2013 Systemisches inflammatorisches Response-Syndrom? (ICD-10-GM\u00a0Nr.\u00a01007). https:\/\/www.dimdi.de\/dynamic\/de\/klassifikationen\/kodierfrage\/Was-versteht-man-unter-SIRS-Systemisches-inflammatorisches-Response-Syndrom-ICD-10-GMnbspNr.nbsp1007\/. Zugegriffen: 23. Apr. 2021"},{"key":"1012_CR3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0854OC","author":"MM Churpek","year":"2016","unstructured":"Churpek\u00a0MM, Snyder\u00a0A, Han\u00a0X et\u00a0al (2016) qSOFA, SIRS, and early warning scores for detecting clinical deterioration in infected patients outside the ICU. Am J Respir Crit Care Med. https:\/\/doi.org\/10.1164\/rccm.201604-0854OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1012_CR4","volume-title":"S3-Leitlinie Sepsis \u2013 Pr\u00e4vention, Diagnose, Therapie und Nachsorge","author":"F Brunkhorst","year":"2018","unstructured":"Deutsche Sepsis Gesellschaft e.\u202fV., Brunkhorst\u00a0F, Weigand\u00a0MA et al (2018) S3-Leitlinie Sepsis \u2013 Pr\u00e4vention, Diagnose, Therapie und Nachsorge"},{"key":"1012_CR5","volume-title":"Sepsisdefinition und -kodierung","author":"Deutsche Sepsis-Gesellschaft","year":"2019","unstructured":"Deutsche Sepsis-Gesellschaft (2019) Sepsisdefinition und -kodierung"},{"key":"1012_CR6","unstructured":"Deutsches Institut f\u00fcr Medizinische Dokumentation und Information (2020) DIMDI \u2013 ICD-10-GM Version\u00a02020. https:\/\/www.dimdi.de\/static\/de\/klassifikationen\/icd\/icd-10-gm\/kode-suche\/htmlgm2020\/zusatz-03-kommentar.htm. Zugegriffen: 23. Apr. 2021"},{"key":"1012_CR7","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1473-3099(17)30117-2","volume":"17","author":"JP Donnelly","year":"2017","unstructured":"Donnelly\u00a0JP, Safford\u00a0MM, Shapiro\u00a0NI et al (2017) Application of the Third International Consensus Definitions for Sepsis (Sepsis-3) classification: a\u00a0retrospective population-based cohort study. Lancet Infect Dis 17:661\u2013670. https:\/\/doi.org\/10.1016\/S1473-3099(17)30117-2","journal-title":"Lancet Infect Dis"},{"key":"1012_CR8","volume-title":"Thesen der AWMF zu Aufgaben von Universit\u00e4tskliniken","author":"A Encke","year":"2005","unstructured":"Encke\u00a0A, Wichert\u00a0P (2005) Thesen der AWMF zu Aufgaben von Universit\u00e4tskliniken Bd. 4"},{"key":"1012_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jama.2016.20329","volume":"317","author":"Y Freund","year":"2017","unstructured":"Freund\u00a0Y, Lemachatti\u00a0N, Krastinova\u00a0E et al (2017) Prognostic accuracy of sepsis\u20113 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA 317:301\u2013308. https:\/\/doi.org\/10.1001\/jama.2016.20329","journal-title":"JAMA"},{"key":"1012_CR10","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00103-018-2755-6","volume":"61","author":"R Jakob","year":"2018","unstructured":"Jakob\u00a0R (2018) ICD-11 \u2013 Anpassung der ICD an das 21. Jahrhundert. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 61:771\u2013777. https:\/\/doi.org\/10.1007\/s00103-018-2755-6","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"1012_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-018-0465-y","author":"U Keppler","year":"2018","unstructured":"Keppler\u00a0U, Schmoch\u00a0T, Siegler\u00a0BH et al (2018) Implementation of the Sepsis\u20113 definition in German university intensive care units. Anaesthesist. https:\/\/doi.org\/10.1007\/s00101-018-0465-y","journal-title":"Anaesthesist"},{"key":"1012_CR12","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1097\/CCM.0000000000003360","volume":"46","author":"DR Kievlan","year":"2018","unstructured":"Kievlan\u00a0DR, Zhang\u00a0LA, Chang\u00a0C\u2011CH et al (2018) Evaluation of repeated quick sepsis-related organ failure assessment measurements among patients with suspected infection. Crit Care Med 46:1906. https:\/\/doi.org\/10.1097\/CCM.0000000000003360","journal-title":"Crit Care Med"},{"key":"1012_CR13","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","volume":"31","author":"MM Levy","year":"2003","unstructured":"Levy\u00a0MM, Fink\u00a0MP, Marshall\u00a0JC et\u00a0al (2003) 2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250\u20131256. https:\/\/doi.org\/10.1097\/01.CCM.0000050454.01978.3B","journal-title":"Crit Care Med"},{"key":"1012_CR14","volume-title":"Sepsis guidance implementation advice for adults","author":"NHS England","year":"2017","unstructured":"NHS England (2017) Sepsis guidance implementation advice for adults"},{"key":"1012_CR15","unstructured":"Osterloh F (2020) Intensivbetten: Die Kapazit\u00e4ten schwinden. https:\/\/www.aerzteblatt.de\/archiv\/216577\/Intensivbetten-Die-Kapazitaeten-schwinden. Zugegriffen: 12. Nov. 2020"},{"key":"1012_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-021-00916-9","author":"T Schmoch","year":"2021","unstructured":"Schmoch\u00a0T, Brenner\u00a0T, Becker-Pennrich\u00a0A et al (2021) Therapie der Sepsis-induzierten Koagulopathie. Ergebnisse einer deutschlandweiten Umfrage auf Intensivstationen. Anaesthesist. https:\/\/doi.org\/10.1007\/s00101-021-00916-9","journal-title":"Anaesthesist"},{"key":"1012_CR17","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1001\/jama.2016.0288","volume":"315","author":"CW Seymour","year":"2016","unstructured":"Seymour\u00a0CW, Liu\u00a0VX, Iwashyna\u00a0TJ et al (2016) Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:762\u2013774. https:\/\/doi.org\/10.1001\/jama.2016.0288","journal-title":"JAMA"},{"key":"1012_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer\u00a0M, Deutschman\u00a0CS, Seymour\u00a0CW et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"1012_CR19","volume-title":"Gesundheit Grunddaten der Krankenh\u00e4user","author":"Statistisches Bundesamt","year":"2020","unstructured":"Statistisches Bundesamt (2020) Gesundheit Grunddaten der Krankenh\u00e4user (130)"},{"key":"1012_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.057","author":"JM Williams","year":"2016","unstructured":"Williams\u00a0JM, Greenslade\u00a0JH, McKenzie\u00a0JV et\u00a0al (2016) SIRS, qSOFA and organ dysfunction: insights from a\u00a0prospective database of emergency department patients with infection. Chest. https:\/\/doi.org\/10.1016\/j.chest.2016.10.057","journal-title":"Chest"},{"key":"1012_CR21","unstructured":"World Health Organisation (2009) ICD-10 international classification of mortality and morbidity statistics - tenth revision. http:\/\/www.dimdi.de\/static\/de\/klassi\/diagnosen\/icd10\/htmlgm2010\/block-c69-c72.htm. Zugegriffen: 29. Okt. 2009"},{"key":"1012_CR22","unstructured":"World Health Organisation (2020) ICD-11 international classification of mortality and morbidity statistics - eleventh revision. https:\/\/icd.who.int\/en. Zugegriffen: 16. Nov. 2020"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-021-01012-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-021-01012-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-021-01012-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T18:02:57Z","timestamp":1643738577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-021-01012-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s00101-021-01012-8","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]},"assertion":[{"value":"31 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Schmoch: Vortragshonorar: Mitsubishi Tanabe Pharma GmbH. P.\u00a0M\u00f6hnle: Erstattung von Kongressgeb\u00fchren, Reise- und \u00dcbernachtungskosten, Vortragshonorare: Bayer, Biotest, CSL Behring, Novo Nordisk, Pfizer, Roche, Shire\/Takeda, SOBI Advisory Board: CSL Behring. T.\u00a0Brenner: Vortrags- & Vorsitzhonorare: Baxter Deutschland GmbH, Sch\u00f6chl medical education GmbH, Boehringer Ingelheim Pharma GmbH, CSL Behring GmbH, Astellas Pharma GmbH. M.A.\u00a0Weigand: Vortragshonorare: GE-Healthcare, Gilead, K\u00f6hler Chemie, MSD Sharp & Dohme, Pfizer Pharma, Boehringer Ingelheim; Advisory Boards: B.\u00a0Braun, Gilead, MSD Sharp & Dohme, Shionogi. M.\u00a0Bernhard, A.\u00a0Becker-Pennrich, L.C.\u00a0Hinske, J.\u00a0Briegel geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}